Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken J Harvey

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Medical Journal of Australia|October 8, 2011
"I want to consume this product; should public health experts stop me?"--Yes--Opposing viewsKen J Harvey
Australian Health Review : a Publication of the Australian Hospital Association|July 1, 2009
A review of proposals to reform the regulation of complementary medicinesKen J Harvey
The Medical Journal of Australia|June 10, 2010
Hydroxycut hepatotoxicity. CommentKen J Harvey
Australia and New Zealand Health Policy|February 1, 2005
The Pharmaceutical Benefits Scheme 2003-2004Ken J Harvey
The Medical Journal of Australia|February 1, 2003
eTG completeKen J Harvey
The Medical Journal of Australia|June 15, 2007
The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture?Ken J Harvey, Anthony H Harris, Liliana Bulfone
The Medical Journal of Australia|September 7, 2004
Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?Ken J Harvey, Thomas A Faunce, Buddhima Lokuge, et al.
The Medical Journal of Australia|June 8, 2011
Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?Ken J Harvey, Richard O Day, William G Campbell, et al.
The Medical Journal of Australia|January 22, 2008
Commercialism, choice and consumer protection: regulation of complementary medicines in AustraliaKen J Harvey, Viola S Korczak, Loretta J Marron, et al.
The Medical Journal of Australia|July 19, 2005
Pharmaceutical advertisements in prescribing software: an analysisKen J Harvey, Agnes I Vitry, Elizabeth Roughead, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Medical Journal of Australia|October 8, 2011
"I want to consume this product; should public health experts stop me?"--Yes--Opposing viewsKen J Harvey
Australian Health Review : a Publication of the Australian Hospital Association|July 1, 2009
A review of proposals to reform the regulation of complementary medicinesKen J Harvey
The Medical Journal of Australia|June 10, 2010
Hydroxycut hepatotoxicity. CommentKen J Harvey
Australia and New Zealand Health Policy|February 1, 2005
The Pharmaceutical Benefits Scheme 2003-2004Ken J Harvey
The Medical Journal of Australia|February 1, 2003
eTG completeKen J Harvey
The Medical Journal of Australia|June 15, 2007
The National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2007: reform or fracture?Ken J Harvey, Anthony H Harris, Liliana Bulfone
The Medical Journal of Australia|September 7, 2004
Will the Australia-United States Free Trade Agreement undermine the Pharmaceutical Benefits Scheme?Ken J Harvey, Thomas A Faunce, Buddhima Lokuge, et al.
The Medical Journal of Australia|June 8, 2011
Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration?Ken J Harvey, Richard O Day, William G Campbell, et al.
The Medical Journal of Australia|January 22, 2008
Commercialism, choice and consumer protection: regulation of complementary medicines in AustraliaKen J Harvey, Viola S Korczak, Loretta J Marron, et al.
The Medical Journal of Australia|July 19, 2005
Pharmaceutical advertisements in prescribing software: an analysisKen J Harvey, Agnes I Vitry, Elizabeth Roughead, et al.
Pageof 1